Sulphonylurea monotherapy for patients with type 2 diabetes mellitus

Bianca Hemmingsen; Jeppe B Schroll; Søren Lund; Jørn Wetterslev; Christian Gluud; Allan Vaag; David Peick Sonne; Lars Hyldborg Lundstrøm; Thomas Almdal

doi:10.1002/14651858.CD009008.pub2

Sulphonylurea monotherapy for patients with type 2 diabetes mellitus

Bianca Hemmingsen, Jeppe B Schroll, Søren Lund, Jørn Wetterslev, Christian Gluud, Allan Vaag, David Peick Sonne, Lars Hyldborg Lundstrøm, Thomas Almdal

61 Citationer (Scopus)

Abstract

Type 2 diabetes mellitus (T2DM) is a growing health problem worldwide. Whether sulphonylureas show better, equal or worse therapeutic effects in comparison with other antidiabetic interventions for patients with T2DM remains controversial.

Originalsprog	Engelsk
Tidsskrift	Cochrane Database of Systematic Reviews
Vol/bind	4
Sider (fra-til)	CD009008
ISSN	1469-493X
DOI	https://doi.org/10.1002/14651858.CD009008.pub2
Status	Udgivet - 2013

Adgang til dokumentet

10.1002/14651858.CD009008.pub2

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{c2c5a9c9cdbb43908d580ca64828ab04,

title = "Sulphonylurea monotherapy for patients with type 2 diabetes mellitus",

abstract = "Type 2 diabetes mellitus (T2DM) is a growing health problem worldwide. Whether sulphonylureas show better, equal or worse therapeutic effects in comparison with other antidiabetic interventions for patients with T2DM remains controversial.",

author = "Bianca Hemmingsen and Schroll, \{Jeppe B\} and S{\o}ren Lund and J{\o}rn Wetterslev and Christian Gluud and Allan Vaag and Sonne, \{David Peick\} and Lundstr{\o}m, \{Lars Hyldborg\} and Thomas Almdal",

year = "2013",

doi = "10.1002/14651858.CD009008.pub2",

language = "English",

volume = "4",

pages = "CD009008",

journal = "Cochrane Database of Systematic Reviews",

issn = "1469-493X",

publisher = "John Wiley and Sons Ltd",

}

TY - JOUR

T1 - Sulphonylurea monotherapy for patients with type 2 diabetes mellitus

AU - Hemmingsen, Bianca

AU - Schroll, Jeppe B

AU - Lund, Søren

AU - Wetterslev, Jørn

AU - Gluud, Christian

AU - Vaag, Allan

AU - Sonne, David Peick

AU - Lundstrøm, Lars Hyldborg

AU - Almdal, Thomas

PY - 2013

Y1 - 2013

N2 - Type 2 diabetes mellitus (T2DM) is a growing health problem worldwide. Whether sulphonylureas show better, equal or worse therapeutic effects in comparison with other antidiabetic interventions for patients with T2DM remains controversial.

AB - Type 2 diabetes mellitus (T2DM) is a growing health problem worldwide. Whether sulphonylureas show better, equal or worse therapeutic effects in comparison with other antidiabetic interventions for patients with T2DM remains controversial.

UR - https://www.scopus.com/pages/publications/84880656964

U2 - 10.1002/14651858.CD009008.pub2

DO - 10.1002/14651858.CD009008.pub2

M3 - Journal article

C2 - 23633364

SN - 1469-493X

VL - 4

SP - CD009008

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

ER -

Sulphonylurea monotherapy for patients with type 2 diabetes mellitus

Abstract

Adgang til dokumentet

Andre filer og links

Fingeraftryk

Citationsformater